Home / drug / D-0003-2026 Class II Reported 2025-10-15
Bevacizumab 1.75 mg/0.07 mL - 0.25 mL syringe, Intravitreal, 0.07 mL Total Volume, Rx Only, Hospital/Office Use Only, Refrigerate, RC Outsourcing LLC, Lowellville, OH 44436. Recalled by RC Outsourcing, LLC
Reason for Recall Lack of assurance of sterility.
Advertisement
Was this product in your home? Find safe, vetted alternatives. We may earn a commission on qualifying purchases.
Browse Safer Alternatives
Recall Number D-0003-2026
Classification Class II
Status Terminated
Category drug
Initiated 2025-09-22
Reported 2025-10-15
Distribution Nationwide in the US
Code Info Lot # 20250708-768A26, BUD: Oct 06, 2025 20250715-944DF2 BUD: Oct 13, 2025 20250722-55C603 BUD: Oct 20, 2025 20250722-5DC113 BUD: Oct 20, 2025 Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer .